Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: A pilot study

International Journal of Cancer

Volumn 88, Issue 2, 2000, Pages 232-238

  Janetzki, Sylvia ^a   Palla, Dirk ^a   Rosenhauer, Valentino ^a   Lochs, Heribert ^a   Lewis, Jonathan J ^c   Srivastava, Pramod K ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD8 ANTIGEN; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOIMMUNITY; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, NEOPLASM; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEAT-SHOCK PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMAN; KILLER CELLS, NATURAL; MALE; MIDDLE AGE; NEOPLASMS; PILOT PROJECTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME;

EID: 0033819308     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001015)88:2<232::AID-IJC14>3.0.CO;2-8     Document Type: Article

References (24)

1. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
2. The enigma of the natural killer cell
3. Membranes activate tumor- and virus-specific precursor cytotoxic T lymphocytes in vivo and stimulate tumor-specific T lymphocytes in vitro: Implications for vaccination
4. + T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens
5. In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites
6. Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo
7. Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes
8. T cells against a bacterial heat shock protein recognize stressed macrophages
9. Immune regulation: A critical link between NK cells and CTLs
10. Stress proteins may provide a link between the immune response to infection and autoimmunity
11. + T cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide
12. Heat shock proteins and autoimmune thyroid disease; too hot to handle?
13. Autoantibodies to the heat-shock protein hsp90 in systemic lupus erythematosus
14. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
15. Immunization of patients with melanoma peptide vaccines: Immunological assessment using the Elispot assay
16. Natural killer cell receptors: The offs and ons of NK cell recognition
17. Immunological and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
18. Tumor rejection antigens of chemically induced sarcomas of inbred mice
19. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
20. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
21. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations
22. Heat-shock proteins as immunogenic bacterial antigens with the potential to induce and regulate autoimmune arthritis
23. Arthritis induced by a T-lymphocyte clone that responds to Myobacterium tuberculosis and to cartilage proteoglycans